10 Stocks That Will Change the World by 2030
Artificial intelligence, robotics and gene editing are moving from research demonstrations into products that can alter how people work, manufacture goods and receive treatment.
Crispr Therapeutics Ag (CRSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 9,460,939 | $515,999,631 | -17% | 3.35% |
| 2. | Orbis Investment Management William B. Gray | 5,449,161 | $297,197,241 | -11% | 1.02% |
| 3. | SR One Capital Simeon George | 2,038,763 | $111,194,134 | 10.7% | |
| 4. | EcoR1 Capital Oleg Nodelman | 1,389,276 | $75,771,113 | 3.68% | |
| 5. | D E Shaw D. E. Shaw | 893,812 | $48,748,506 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.96 | 1,508 | $49,703.68 | 1,508 | 2025-04-03 | Filing | |
| $57.03 | 20,000 | $1,140,600.00 | 22,000 | 2025-08-06 | Filing | |
| $52.03 | 960,983 | $49,999,945.49 | 1,730,179 | 2025-07-16 | Filing | |
| $52.03 | 22,319 | $1,161,257.57 | 238,897 | 2025-07-16 | Filing | |
| $52.03 | 6,510 | $338,715.30 | 69,687 | 2025-07-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.24 | 10,400 | $626,459.60 | 94,784 | 2026-09-22 | Filing | |
| $57.09 | 13,679 | $780,935.48 | 16,637 | 2026-09-17 | Filing | |
| $55.62 | 3,786 | $210,577.32 | 19,357 | 2026-05-29 | Filing | |
| $46.78 | 3,182 | $148,853.96 | 94,308 | 2026-03-23 | Filing | |
| $46.78 | 10,020 | $468,735.60 | 255,501 | 2026-03-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 111,230 | $6,153,244 | 0.04% | |
| 2. | 20,097 | $1,111,766 | 0.12% | |
| 3. | 1,078 | $59,635 | 0.01% | |
| 4. | 150 | $8,298 | 0% | |
| 5. | 8 | $443 | 0% |
News See All
Failure of Novartis' Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
Novartis AG’s (NYSE:NVS) Phase 3 Lp(a)HORIZON setback carries implications beyond the Swiss drugmaker.
Billionaire Ken Fisher Was Buying These 2 Cathie Wood Stocks
Q2 13F filings show that billionaire Ken Fisher’s Fisher Asset Management opened new positions in CRISPR Therapeutics (NASDAQ: CRSP) and Coinbase Global (NASDAQ: COIN).
Cathie Wood Sells $28.6M of Alphabet Stock and Buys $26.4M of Meta Shares. What Else Is She Buying?
Cathie Wood’s ARK Invest bought 43,091 shares of Meta Platforms ($META) worth about $26.4 million on Wednesday, September 9. The firm also added ab...
10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now
In this article, we will discuss the 10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now.
10 Under-the-Radar Stocks with Massive Upside for 2026
In this piece, we discuss the 10 Under-the-Radar Stocks with Massive Upside for 2026. The earnings season, which carried equities to record highs, is largely over.
10 Best ARK Stocks to Buy Right Now
In this article, we will discuss: 10 Best ARK Stocks to Buy Right Now.
10 Best European Growth Stocks to Buy
In this article, we will look at the 10 Best European Growth Stocks to Buy. European growth stocks are getting another look as investors search for earnings growth outside the usual U.S.
CRISPR (CRSP) Rated Overweight on Gene Editing Growth
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years.
10 Stocks That Could 10X Over the Next 10 Years
In this article, we will take a look at the 10 Stocks That Could 10X Over the Next 10 Years.